Search results for “Ofatumumab” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 107 patents, we discovered top 22 key players by total patent application. Novartis AG, Gilead Calistoga LLC, ZymoGenetics, Inc. are dominant in this area. They take 78.50% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 53
California, United States
Patent: 24
Washington, United States
Patent: 7
Switzerland
Patent: 7
Xizang Zizhiqu, China
Patent: 4
California, United States
Patent: 3
Pennsylvania, United States
Patent: 3
New Jersey, United States
Patent: 1
Osaka-fu, Japan
Patent: 1
Connecticut, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 36 patents applied in the last 5 years. We discover 4 most active companies in this area. The fast-growing Novartis AG, Novartis Pharmaceuticals Corp., Suzhou Yasheng Pharmaceutical Co., Ltd. take 100.00% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 34
New Jersey, United States
Patent: 1
Jiangsu Sheng, China
Patent: 1
Belgium
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 36 patents in last 5 years, we discover 3 new entrants.
New Jersey, United States
Patent: 1
Jiangsu Sheng, China
Patent: 1
Belgium
Patent: 1
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: